ZEROWAVE-D TAB is a specialized formulation designed for the effective treatment of migraines. This combination product features flunarizine, a calcium channel blocker, and domperidone, an antiemetic agent, working together to alleviate the symptoms associated with migraine headaches. By addressing both the vascular changes and gastrointestinal disturbances often experienced during migraines, ZEROWAVE-D TAB provides comprehensive relief, allowing individuals to regain control over their daily activities.
Flunarizine: Flunarizine is a calcium channel blocker that helps prevent the dilation of blood vessels in the head, which is believed to be a contributing factor to migraine headaches. By stabilizing vascular tone, flunarizine reduces the frequency and intensity of migraine attacks.
Domperidone: Domperidone is an antiemetic that works by blocking dopamine receptors in the gastrointestinal tract. It helps relieve nausea and vomiting, common symptoms associated with migraines, thus enhancing the overall therapeutic effect of the treatment.
Effective migraine relief: The combination of flunarizine and domperidone targets both the vascular and gastrointestinal aspects of migraines, providing comprehensive relief from headache and related symptoms.
Reduces nausea and vomiting: By addressing gastrointestinal symptoms, domperidone helps patients manage the discomfort often accompanying migraine attacks, allowing for improved overall well-being.
Prevents migraine recurrence: Flunarizine helps stabilize blood vessels, potentially reducing the frequency of future migraine episodes and improving patients' quality of life.
Convenient combination therapy: The dual-action formulation of ZEROWAVE-D TAB offers a streamlined approach to migraine management, reducing the need for multiple medications.
ZEROWAVE-D TAB is generally well-tolerated; however, some patients may experience side effects such as drowsiness, dry mouth, dizziness, or gastrointestinal disturbances. It is essential to follow dosing instructions and consult a healthcare provider if symptoms persist or worsen. This product is contraindicated in patients with known hypersensitivity to flunarizine or domperidone, as well as those with specific medical conditions such as prolactin-secreting tumors, severe liver disease, or existing heart conditions. Pregnant or breastfeeding women should seek medical advice before using this medication.
ZEROWAVE-D TAB by Medicox Life Science is an effective solution for those suffering from migraines, combining the benefits of two potent ingredients to address the multifaceted nature of migraine headaches. Its unique formulation not only targets the headache itself but also mitigates accompanying symptoms like nausea, making it a reliable choice for comprehensive migraine management. With a commitment to quality and safety, Medicox Life Science ensures that each dose of ZEROWAVE-D TAB delivers consistent and effective relief, empowering patients to manage their migraines effectively.
Mental and neurological health is important, and our range of products supports the treatment of these conditions. Our PCD Pharma partners can provide effective solutions for those who need them, ensuring quality care in neuro and psychiatric health.
Join as a partner, dealer, or distributor to deliver quality healthcare solutions across India.
Get in Touch